Evidence map›Paper›PMID 33115909›Full record

ReviewPostgraduate medical journal2021

Will vaccination refusal prolong the war on SARS-CoV-2?

Robert Marcec, Matea Majta, Robert Likic

Open access · hybridFull text readReview
In one paragraph

Review in Postgraduate medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Robert MarcecUniversity of Zagreb School of Medicine, Zagreb, Croatia.ORCID http://orcid.org/0000-0002-8750-2083
Matea MajtaUniversity of Zagreb School of Medicine, Zagreb, Croatia.ORCID http://orcid.org/0000-0001-7004-8876
Robert LikicDepartment of Internal Medicine, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Zagreb, Croatia robert.likic@mef.hr rlikic@kbc-zagreb.hr.ORCID http://orcid.org/0000-0003-1413-4862
University of Zagreb · HRUniversity Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use. MATERIALS AND

methodsWe collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries.

resultsThe pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination.

conclusionIt is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic.

Indexed as

Attitude to HealthVaccination RefusalCOVID-19COVID-19 VaccinesEuropeHealth EducationHumansImmunity, HerdPublic OpinionSARS-CoV-2Surveys and QuestionnairesCOVID-19 VaccinesClinical pharmacologyInfection controlInfectious diseasesPublic health

Identifiers

PMID33115909
PMCPMC10016907
OpenAlexW3097835659

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read50
reference markers read7
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.